Bioherent in an equity deal with Axon Partners Group, Bullnet Capital and CDTI-Innvierte.
07 July 2025
07 July 2025
Total investments received (USD): 2.3m
Round value (USD): 2.3m
Company: Bioherent
Related deals
Atlas Molecular Pharma closed a €3 million deal led by Inveready, joined by CDTI, Grupo SPRI, Kereon Partners, Endometrial DIDI, and CRB Inverbio
Investments
04 January 2026
Adaptam Therapeutics raised a €3 million pre-seed financing round led by Criteria Bio Ventures.
Investments
13 October 2025
Neuronoff raised $4.5 million
Investments
02 October 2025
Blue Box Biomedical Solutions raised €3m led by Unconventional Ventures, joined by Fund F, Grow Ventures, Hans(wo)man Group, and the Foss/Krups family.
Investments
02 July 2025
Ideeea Therapeutics raised €2.3M in a seed round
Investments
09 May 2025
Netherlands
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal